Virtu Financial LLC Takes $1.46 Million Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Key Points

• Virtu Financial LLC has acquired a new position in Intuitive Surgical, Inc., purchasing 2,955 shares valued at approximately $1.46 million during the first quarter.
• Insider transactions revealed that Gary S. Guthart sold 2,800 shares for about $1.39 million, resulting in a 13.13% decrease in his ownership.
• Various firms have adjusted their ratings on Intuitive Surgical; while Robert W. Baird lowered its price target, others like Piper Sandler and Wells Fargo have increased their target prices and maintained positive ratings.

Virtu Financial LLC bought a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 2,955 shares of the medical equipment provider's stock, valued at approximately $1,463,000.

Several other hedge funds and other institutional investors have also made changes to their positions in ISRG. Castleark Management LLC increased its holdings in shares of Intuitive Surgical by 3.4% in the fourth quarter. Castleark Management LLC now owns 90,469 shares of the medical equipment provider's stock valued at $47,221,000 after purchasing an additional 2,990 shares during the last quarter. Arlington Trust Co LLC increased its holdings in shares of Intuitive Surgical by 34.5% in the first quarter. Arlington Trust Co LLC now owns 745 shares of the medical equipment provider's stock valued at $369,000 after purchasing an additional 191 shares during the last quarter. Aaron Wealth Advisors LLC increased its holdings in shares of Intuitive Surgical by 3.2% in the first quarter. Aaron Wealth Advisors LLC now owns 2,509 shares of the medical equipment provider's stock valued at $1,243,000 after purchasing an additional 78 shares during the last quarter. Longbow Finance SA increased its holdings in shares of Intuitive Surgical by 132.0% in the first quarter. Longbow Finance SA now owns 19,699 shares of the medical equipment provider's stock valued at $9,756,000 after purchasing an additional 11,209 shares during the last quarter. Finally, Ewing Morris & Co. Investment Partners Ltd. acquired a new stake in shares of Intuitive Surgical in the fourth quarter valued at approximately $454,000. Hedge funds and other institutional investors own 83.64% of the company's stock.

Insider Activity

In other news, insider Gary S. Guthart sold 2,800 shares of the business's stock in a transaction dated Monday, July 28th. The stock was sold at an average price of $495.24, for a total value of $1,386,672.00. Following the completion of the sale, the insider directly owned 18,520 shares of the company's stock, valued at approximately $9,171,844.80. The trade was a 13.13% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Myriam Curet sold 4,500 shares of the business's stock in a transaction dated Friday, July 25th. The shares were sold at an average price of $492.48, for a total value of $2,216,160.00. Following the completion of the sale, the executive vice president directly owned 353 shares of the company's stock, valued at $173,845.44. The trade was a 92.73% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 15,881 shares of company stock valued at $7,920,634. Insiders own 0.70% of the company's stock.

Intuitive Surgical Trading Up 1.3%

ISRG traded up $6.34 on Tuesday, hitting $478.19. 1,529,402 shares of the company were exchanged, compared to its average volume of 2,211,435. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $616.00. The company has a market cap of $171.42 billion, a price-to-earnings ratio of 66.69, a price-to-earnings-growth ratio of 4.95 and a beta of 1.59. The firm has a 50-day moving average price of $513.42 and a two-hundred day moving average price of $527.10.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, topping the consensus estimate of $1.93 by $0.26. The firm had revenue of $2.44 billion during the quarter, compared to analysts' expectations of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%. Intuitive Surgical's revenue for the quarter was up 21.4% on a year-over-year basis. During the same period in the previous year, the firm posted $1.78 EPS. Equities analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Analysts Set New Price Targets

Several equities research analysts recently commented on the company. Royal Bank Of Canada increased their price target on Intuitive Surgical from $605.00 to $615.00 and gave the company an "outperform" rating in a report on Wednesday, July 23rd. Wells Fargo & Company increased their price target on Intuitive Surgical from $559.00 to $599.00 and gave the company an "overweight" rating in a report on Wednesday, July 23rd. Piper Sandler reaffirmed an "overweight" rating and issued a $595.00 price target (up previously from $575.00) on shares of Intuitive Surgical in a report on Wednesday, July 23rd. UBS Group increased their price target on Intuitive Surgical from $547.00 to $585.00 and gave the company a "neutral" rating in a report on Wednesday, July 23rd. Finally, Wall Street Zen raised Intuitive Surgical from a "hold" rating to a "buy" rating in a research note on Saturday, July 26th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have issued a buy rating to the stock. According to MarketBeat.com, Intuitive Surgical presently has a consensus rating of "Moderate Buy" and an average target price of $595.95.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.